Cyanobacteria and Microalgae in the Production of Valuable Bioactive Compounds by Martínez-Francés, Elena & Escudero-Oñate, Carlos
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 6
Cyanobacteria and Microalgae in the Production of
Valuable Bioactive Compounds
Elena Martínez-Francés and Carlos Escudero-Oñate
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.74043
Abstract
In the last decades, an increasing attention has been directed toward the possibilities of
growing algae commercially. This interest has been partially due to the fact that some
strains of microalgae and cyanobacteria have demonstrated the ability to produce a
variety of bioactive products. Both, primary and secondary metabolism of these microor-
ganisms has been demonstrated to play a key role in the production of special chemicals.
Antioxidants, for instance, can be produced by some algal strains to protect photosyn-
thetic cells from oxidative stress. Microalgae can produce a variety of polyunsaturated
and monounsaturated fatty acids with clear health benefits for human nutrition. Potential
products obtained from cyanobacteria and microalgae exhibiting interesting medical
properties include polysaccharides, glycerol, glycoproteins, and antibiotics. From the
aforementioned products, especially relevant has become the search of new antibiotics.
The potential spread of bacterial resistance and the foreseen decrease on efficiency on
antibiotics, has largely stimulated the research on novel antibiotics sources. Among these
sources, cyanobacteria and microalgae have demonstrated a vast and just barely explored
potential.
Keywords: bioactive products, pharmaceuticals, primary and secondary metabolism,
microalgae, cyanobacteria, antibiotics
1. Introduction
Cyanobacteria (prokaryotic green-blue algae) and microalgae (eukaryotic microalgae) are reg-
ularly found in water bodies, desert crusts, or even in symbiosis with other animals. They can
live in large varieties of environmental conditions, including low or high temperatures, high-
light intensities, pH and salinity [1]. In the last decades, increasing attention has been paid to
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the potential of growing these kinds of organisms with commercial purposes. Part of the
added value of this type of biomass is based on the fact that it can be used in human and
animal nutrition (i.e. fish feed in aquaculture facilities). Moreover, some extracts from
microalgae can be used to produce cosmetics and a variety of different bioactive products,
such as pharmaceutical compounds [2–4]. The diversity of cyanobacteria and microalgae is
immense, with species, genera, or even classes being discovered every year. On the estimated
millions of exiting species, about 30,000 have been described; but nowadays, not more than a
dozen is regularly cultivated and exploited in large scale for commercial biotechnological
purposes. On top of that, research on how the culture conditions affect the production of
important bioactive substances remains nowadays very scarce. Some authors, such as Spoehr
and Milner [5], proved that manipulating microalgae or cyanobacteria growth conditions, for
instance, by applying different forms of stress to the cells, could promote the production of
biomass with valuable secondary metabolites, some of which presents pharmaceutical and/or
industrial values. In most of the cases, the production of valuable metabolic products by
cyanobacteria and microalgae is a two-step process. In the first step, the microorganisms are
grown under optimal conditions to maximize the production of biomass. This process is
followed by a second step where stress factors, such as high light intensity or nutrients depri-
vation, are applied to the culture to induce the production of valuable secondary metabolites
with the pursued pharmaceutical [6, 7] or antioxidant properties. In this chapter, the produc-
tion of a variety of bioactive compounds by cyanobacteria and microalgae has been reviewed.
2. Valuable bioactive products from cyanobacteria and microalgae
Variations in temperature, light, pH, salinity and nutrient availability have been extensively
investigated to study their impact on microalgae growth and their primary and secondary
metabolic products. Primary metabolites are those directly involved in normal growth devel-
opment, reproduction, cell division, or metabolism. They include for instance the production of
lipid, such as polyunsaturated fatty acids (PUFA) [8–11], antioxidants such as carotenoids, and
some types of proteins (Figure 1). Secondary metabolites are those compounds that are not
used by organisms for their primary needs and include compounds that act as hormones,
antibiotics, or toxins, among others [12]. The production of secondary metabolites appears to
be specie and strain specific [13], and is possibly associated to the exposure of the microorgan-
ism to specific environmental conditions [6, 14] caused, for instance, by stress factors. In a study
carried out by Lustigaman in 1988, the production of antibiotic activity by Dunaliella spp. was
investigated. The study was based on isolating extracts of these microalgae from two different
environmental scenarios; one clean and one polluted water system. The study demonstrated
that nonproteinous substances inhibiting the activity of the bacteria Escherichia coli were only
produced by the microalgae Dunaliella spp. under exposure to the polluted water. It was,
therefore, suggested that microalgae growing in adverse conditions are more likely to produce
secondary metabolites with antibacterial activity [15].
Nowadays, the major products obtained from microalgae with industrial use are carotenoids
and algal biomass, which are mainly used for human and animal feed and for aquaculture.
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Microalgae can also produce other antioxidants, such as vitamins C and E, and even butylated
hydroxytoluene (BHT). Fatty acids are also produced as primary metabolic products, playing
an important role protecting the cells against oxidative stress. Other metabolic products
obtained from microalgae and exhibiting medical properties are special polysaccharides, glyc-
erol and myscosporine-like amino acids (MAA). In addition to the aforementioned compound
families, glycoproteins, antifreeze proteins and antibiotics can also be produced by these
microorganisms. Some of these substances have demonstrated a set of interesting bioactivities
[11]. An overview of the potential bioactive metabolites is presented in Figure 2.
2.1. Antioxidants
Eukaryotic microalgae and cyanobacteria are often exposed to high oxygen levels and high
irradiance conditions. As a response to this potential oxidative stress, these organisms have
developed defense systems based on the production of different antioxidants. The main goal of
these substances is to preserve cells from oxidative stress, which may otherwise cause damage
to essential biological structures, such as DNA, proteins and lipids. Oxidative stress in humans
and animals can also lead to severe health problems, such as atherogenesis, cancer, neurode-
generative diseases, infant retinopathy, muscular degeneration and renal failure, along with
other problems [17–19]. Dietary intake of antioxidants from these organisms has shown the
ability to limit or prevent certain health issues. For instance, many substances found in algae,
Figure 1. Example of some primary metabolic routes and their products in microalgae. Adapted from Rosenberg et al.
[16].
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such as carotenoids, vitamins C and E or butylated hydroxytoluene (BHT) have such antioxi-
dant effects [11]. Carotenoids have been largely used as supplement in human nutrition as well
as in food and animal feed, poultry and fish. Vitamin C may be found in tablets for human
consumption as well as in meat, where it has been largely used to prevent oxidation processes
and the discoloration of the product during storage. Vitamin E can be commonly found in
supplements for human health and has been largely used in food industry. Another largely
used antioxidant is astaxanthine. This substance has become very popular recently as supple-
ment for human nutrition and is commonly found in, i.e., salmon food formulations to inten-
sify the pigmentation of the fish growth in aquaculture facilities. Table 1 gathers some
examples of microalgae and the type of antioxidant substance that they produce.
Figure 2. Overview of the potential bioactive metabolites produced by microalgae and cyanobacteria. Adapted from
Skjånes et al. [11].
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2.2. Fatty acids and their derivatives
Fatty acids are essential components of the diet. They can occur in the cells as glycolipids and
phospholipids forming the cellular membranes, or as storage products for energy and carbon
in the form of triglycerides [27]. In some cases, triglycerides may also have a role protecting
against oxidative stress, and the lack of these nutrients can cause severe damage to the
organism. Fatty acids can be produced by eukaryotic microalgae and cyanobacteria, and in
some cases they can produce them in large amounts [28]. The truly essential fatty acids are
omega-3 fatty acids, such as linoleic acid and α-linoleic acid. Both humans and animals are
dependent on obtaining them from the diet, because they are used as starting points for
building longer chains of fatty acids. Food supplements of omega-3 are known to have bene-
ficial health effects in the prevention of coronary heart disease, hypertension, type 2 diabetes,
renal disease and chronic obstructive pulmonary disease, among others [29]. A summary
including the production of fatty acids produced by microalgae is presented in Table 2. Some
of the industrial applications of fatty acids include cosmetic formulations, food, personal care,
and pharmaceutical products.
2.3. Polysaccharides
Certain polysaccharides from microalgae have been shown to have remarkable biomedical
properties. Several studies have demonstrated that microalgae, such as Chlorella vulgaris and
Scenedesmus quadricauda are able to presumably produce sulfated polysaccharides that func-
tion as protection against microcystin oxidative stress [35]. Crude polysaccharide extracts
obtained from Chlorella stigmatophora and Phaeodactylum tricornutum showed anti-inflamma-
tory activity in the carrageenan-induced paw edema test [36]. Moreover, other crude polysac-
charide extracts from Chlorella pyrenoidosa presented antitumoral activity against A549 (cell
human lung carcinoma) in vitro [37]. Furthermore, polysaccharides can also present other
Specie of microalgae Type of antioxidant substance Ref.
Botryococcus braunii β-Carotene
BHT
[20, 21]
Chlamydocapsa nivalis Phenolic antioxidants [22]
Chlorella pyrenoidosa Vitamins E [23]
Chlorella spp. Vitamin C [24]
Chlorella vulgaris Vitamins C and E
Lutein (carotenoid)
[20]
[25]
Scenedesmus obliquus Vitamins C and E [20]
Scenedesmus quadricauda Vitamins C and E [23]
Chlamydocapsa spp. Lutein, canthaxanthin and astaxanthin (carotenoids) [26]
Table 1. Antioxidant substances produced by microalgae.
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health-promoting effects on, for instance, gastric ulcers, wounds and constipations [38, 39].
However, their exact function in the algae cells remains still unknown.
2.4. Glycerol
Glycerol can function as osmoregulator and osmoprotector of enzymes. This substance has
been accumulated in substantial amounts in halotolerant species during salt stress conditions.
The production of glycerol in algae is regulated by external water activity, but high light
intensities may inhibit its production [40]. In some cases, the algae can also excrete glycerol as
a response to high concentrations of CO2 rather than salt stress condition [41]. Glycerol is
widely used in cosmetics, pharmaceuticals, paint, food, tobacco, pulp and paper, or in the
production of a large variety of chemicals [42]. Some examples of microalgae producing
glycerol are Brachiomonas submarina [43], Chlamydomonas spp. [41] and Dumaliella salina [44].
Glycerol can be found in a large variety of commercial products and applications, such as
cosmetics and food products, drugs and pharmaceuticals.
2.5. Lectins
Lectins are carbohydrate-binding proteins that are located within protein bodies in the cell.
Lectins from algae have high specificity for complex oligosaccharides, glycoproteins, or glyco-
lipids. They are useful in medical science, for instance, for the detection of disease-related
alterations of glycan synthesis, and for cell markers for diagnosis purposes including infectious
agents, i.e., viruses, bacteria, fungi and/or parasites. Different strains of Chlorella, such as
Chlorella minutissima [45], Chlorella pyrenoidosa [46, 47] and Chlorella spp. [45] produce metabo-
lites with antimicrobial activity and this activity has been preliminary hypothesized to be due
to lectins [47]. Studies conducted with other algae strains, such as Desmococcus olivaceus [45],
Scenedesmus quadricauda [46] and Scenedesmus sp. [45, 48], have reported that the production of
Specie of microalgae Type of fatty acid Ref.
Ankistrodesmus sp. α-linolenic acid [30]
Botryococcus braunii Linoleic acid [31]
Botryococcus spp. α-linolenic acid [31]
Chamydomonas spp. α-linolenic acid [32]
Chlorella minutissima Eicosapentaenoic acid [33]
Scenedesmus obliquus α-linoleic acid
Linoleic acid
[23]
Scenedesmus quadricauda α-linoleic acid [34]
Table 2. Fatty acids produced by microalgae.
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these lectins can be induced by growth-limiting conditions like nutrient deprivation and/or
light stress conditions [49].
Some companies, for instance, Lectin Labs Ltd., have developed lectin formulations, and claim
that these lectins interfere or destroy the development of the disease-causing processes, even in
cases where antibiotics are ineffective.
2.6. Mycosporine-like amino acids
Mycosporine-like amino acids (MAA) are a group of molecules consisting of an amino acid
bound to a chromophore molecule that absorbs light. These amino acids are involved in
protecting the organism against UV radiation and are produced in significant amounts by, for
example, the high UV-tolerant snow algae Chlamydomonas nivalis and other green algae spe-
cies. The production of MAA is induced by exposing the microalgae to UV-light and the
resulting irradiance stress reactions. Nevertheless, there are indicators pointing out that a
decrease in nitrogen levels leads to a decrease in the production of MAA [50, 51]. MAAs from
algae have been explored for commercial purposes which have resulted, for instance, in
commercial skin-care products for UV protection [52]. Some examples of microalgae that
produce MAA are Ankistrodesmus spiralis, Chlorella minutissima, Scenedesmus sp. and Scotiella
nivalis [51].
2.7. Glycoproteins
Glycoproteins are relevant biological structures formed by a protein covalently linked to one or
more carbohydrate units. These structures have a large set of biological functionalities and
some microalgae have demonstrated to be a potential source of them. For instance, a glyco-
protein obtained from Chlorella vulgaris was found to exhibit anticancer activity through anti-
metastatic immunopotentiation [53, 54]. Other microalgae presenting anticancer activity are
Desmococcus olivaceus [45], Scenedesmus sp. [45, 48], Dunaliella bardawil [55] and Dunaliella salina
[44], among others. However, little has been done to identify similar compounds with activity
from other algal species, nor to consider possibilities for optimization of the production of
these glycoproteins by manipulating growth conditions [11].
2.8. Antifreeze proteins
Cold adapted strains of green algae, such as those living in polar environments, are often
producers of antifreeze proteins (AFPs), also designated as ice structuring proteins (ISPs).
These proteins are key elements for the survival of some organisms, since they prevent dam-
ages occurring as a result of very low temperatures. They exhibit unique properties because
they are able to bind to ice crystals, prevent recrystallization and protect other proteins from
damage. AFPs extracted from algae or other microorganisms can be used for cryopreservation,
frozen food preservation, transgenic crops and even weather modification [56–58]. There are
some microalgae such as Chlorella pyrenoidosa that can produce AFPs that additionally exhibit
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antifungal properties [46, 47]. AFPs are currently being explored in some formulations
to reduce cold-induced damage in medical, food and cosmetic products with the target
of lengthening shelf life of the frozen gods. The extraordinary properties of AFPs allow
hypothesizing a growing number of businesses including AFPs in their future formulation of
products.
2.9. Antibiotic activity
Some strains of microalgae can produce metabolites with antibiotic activity aimed at killing or
inhibiting bacterial growth. In some cases, this activity has only been identified in general
extracts from the algal culture, without properly determining the chemical identity of the
active compound/s [45, 47]. There are indications that antibiotics are more likely to occur in
strains isolated from environments polluted by bacteria than in strains isolated from cleaner
environments [59]. For instance, the methanolic extracts of Tetraspora cylindrica present
antibacterial activity against Corynebacterium diphtheria, Klebsiella pneumoniae and Shigella
boydii, among others. These extracts also present antifungal activity against: Curvularia lunata,
Fusarium sporotrichoids, Macrophomina phaseolina, Rhizoctonis solani, Sclerotium rolfsii and
Trichoderma harzianum [60].
In the last decade, the screening and bioprospecting of microalgae and cyanobacteria for
antibiotics and pharmacologically active compounds has received a lot of attention. This is
because a large number of antibiotic compounds, many of them with unusual and novel
structures, have been isolated and characterized from extracts of microalgae [15]. Similarly,
many cyanobacteria have been shown to produce antiviral and antineoplastic compounds. A
range of pharmacological activities have also been observed in some extracts of microalgae
which active principles, in most of the cases, are still unknown. Several of these bioactive
compounds found in microalgae extracts may find application in human or veterinary medi-
cine and agriculture. Others could be used, for instance, as research tools or as structural
models for the development of new drugs [15]. Microalgae are particularly attractive as
natural sources of bioactive molecules because they have the potential to produce these com-
pounds in culture. This enables the production of structurally complex molecules which are
difficult or impossible to produce by chemical synthesis [61].
Many of the antibiotics and pharmaceuticals in current use have their origins in nature and
are the product of systematic screening of terrestrial organisms, such as higher plants and soil
microbes. For instance, of approximately 13500 known naturally occurring antibiotics, 5500
are produced by actinomycetes, while approximately 3300 are produced by higher plants
and, of these, about 90 are in current medical use [62]. Much of the work concerned with the
isolation, screening, and physiology of antibiotic-producing microorganisms has been
focused on heterotrophs. However, very little attention has been paid to other groups, such
as microalgae which are able to grow under diverse nutritional conditions: photo-autotrophi-
cally or chemoheterotrophically [63].
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Moreover, many marine algae produce antibiotics substances that are capable of inhibiting
bacteria, viruses, fungi and other epibionts. It also appears that the antibiotic characteristic is
dependent on many factors, i.e., the algae strain, the microorganisms, the season and the
growth condition [64–67]. Several extractable compounds, for instance, cyclic polysulfides
and halogenated compounds, are toxic to microorganisms and, therefore, responsible for the
antibiotic activity of some marine algae [68–70].
2.9.1. Antibacterial activity of cyanobacteria
Cyanobacteria are phototrophic organisms with a classic prokaryotic cell organization, but
similar to eukaryotes they conduct photosynthesis and respiration in their active membrane
system [71]. Microalgae grow ubiquitously and produce, in addition to toxins, a wide range of
bioactive metabolites with potential application in biotechnology [72]. These characteristics
have made them the focus of intense examination in the last decade [73, 74].
To date, only a few compounds have been extracted and commercialized, including nutraceu-
ticals, cosmetic products and other high-value molecules [39, 75]. Some purified compounds
have promising commercial applications as bioplastics, biofertilizers, antiviral, antifungal,
anticancer and antibacterial drugs [76–78]. Table 3 illustrates some examples of antibacterial,
antifungal and antimycobacterial compounds extracted from cyanobacteria.
2.9.2. Antibacterial activity of microalgae
The production of bioactive compounds from cyanobacteria has received more attention than
from eukaryotic microalgae. The reason may be probably based on the simpler culture
methods available for cyanobacteria growth, and also to their greater resistance to bacterial
contamination [89]. Nevertheless, more and more studies have recently focused on the synthe-
sis of bioactive compounds, such as isoprenoids, polyketides, no ribosomal peptides, polyun-
saturated fatty acids and alkaloids, by eukaryotic microalgae [90], used to inhibit bacterial
activity [6, 91, 92]. In addition, further studies have identified fatty acids, terpenes, carbohy-
drates, glycolipids, lipoproteins, bromophenols and tannins, among other, as compounds that
exhibit antibacterial activity against human pathogens [93, 94].
Microalgae accumulate cell-associated antibacterial substances [95, 96], and some studies have
shown different levels of antibacterial activity in different microalgae cultures [95, 97–99]. More-
over, crude extracts from different species of eukaryotic microalgae have shown effectiveness
against both Gram positive (Gram+) and Gram negative (Gram) bacteria, as well as Mycobacte-
rium tuberculosis [100–104]. This could suggest, therefore, the potential of microalgae for the
production of compounds with a broad-spectrum activity, which is highly desired for the
production of new antibiotics. However, many compounds extracted from these organisms are
likely to be impractical as antibiotics for medical uses as a result of, for instance, its toxicity or
inactivity in vivo [61]. Table 4 presents a summary of the eukaryotic microalgae with the highest
antibacterial activity or the widest spectrum of activity of large screening programs to date.
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Compound Species Chemical structure Molecular formula Activity [79]
Ambigol A [80] Fischerella ambigua [80]
[80]
C18H8Cl6O3 Antibacterial
Antifungal
Fischambiguine B [81] Fischerella ambigua [81]
[81]
C26H29ClN2O2 Antimycobacterial
Ambiguine I isonitrile [82, 83] Fischerella sp. and ambigua [82, 83]
[82, 83]
C26H30N2O2 Antibacterial
Antimycobacterial
Pahayokolide A [84] Lyngbya sp. [84] C72H1 05N13O20 Antibacterial
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Compound Species Chemical structure Molecular formula Activity [79]
[86]
Diterpenoid [87] Nostoc commune [87]
[87]
C22H7O5 Antibacterial
Nostocycline A [88] Nostoc sp. [88]
[88]
C23H34O2 Antibacterial
Adapted from Senhorinho et al. [15].
Table 3. Antibacterial compounds extracted from microalgae.
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Microalgae
specie
Antibacterial compound/Fraction Gram+ inhibition Gram
inhibition
Ref.
Green algae
Chlamydomonas
reinhardtii
Aqueous or methanolic and hexanolic extracts Bacillus subtilis
Staphylococcus
aureus
Staphylococcus
epidermidis
Escherichia
coli
Pseudomonas
aeruginosa
Salmonella
typhi
[106]
Chlorella
minutissima
Ethanolic extracts S. aureus E. coli
P. aeruginosa
[45]
Chlorella
pyrenoidosa
Various organic solvent extracts: ethanol, acetone, diethyl ether, and
methanol
B. subtilis
S. aureus
E. coli
P. aeruginosa
[46]
Chlorella vulgaris Chlorellin B. subtilis
S. aureus
Streptococcus
pyogenes
E. coli
P. aeruginosa
[97]
Chlorella vulgaris Aqueous or methanolic and hexanolic extracts B. subtilis
S. aureus
S. epidermidis
E. coli
P. aeruginosa
S. typhi
[106]
Chlorococcum HS-
101
α-linolenic acid B. subtilis
Bacillus cereus
S. aureus
MRSA
Enterobacter
aerogenes
[107–
109]
Chlorococcum
humicola
Various organic solvent extracts: acetone, benzene, chloroform, diethyl
ether, ethyl acetate, ethanol, hexane, and methanol
Purified pigments: carotenoid and chlorophyll
B. subtilis
S. aureus
E. coli
P. aeruginosa
Salmonella
typhimurium
Klebsiella
pnemoniae
Vibrio
cholerae
[110]
Desmococcus
olivaceus
Ethanolic extracts S. aureus E. coli
P. aeruginosa
[45]
Dunaliella
primolecta
Polyunsaturated fatty acids: α-linolenic acid B. cereus
B. subtilis
S. aureus
MRSA
E. aerogenes [107,
109]
Dunaliella salina Indolic derivative
Polyunsaturated fatty acids
β-ionone and neophytadiene
S. aureus E. coli
P. aeruginosa
[111–
113]
Dunaliella sp. Lysed cells S. epidermidis
Micrococcus luteus
Proteus
vulgaris
[59]
Haemotococcus
pluvialis
Short-chain fatty acids S. aureus E. coli [114,
115]
Klebsormidium sp. Pellet B. Subtilis No effect [116]
Pseudokirchneriella
subcapitata
Methanolic extracts S. aureus P. aeruginosa [111]
Scenedesmus
obliquus
Long-chain fatty acid S. aureus E. coli
P. aeruginosa
Salmonella
sp.
[117]
Scenedesmus
quadricauda
Various organic solvent extracts: ethanol, acetone, diethyl ether, and
methanol
B. subtilis
S. aureus
E. coli
P. aeruginosa
[46]
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Microalgae
specie
Antibacterial compound/Fraction Gram+ inhibition Gram
inhibition
Ref.
Scenedesmus sp. Ethanolic extracts S. aureus E. coli
P. aeruginosa
[45]
Red algae
Porphyridium
aerugineum
Phycobiliproteins S. aureus
S. pyogenes
Not tested [118]
Porphyridium
sordidum
Pellet B. subtilis E. coli
Pseudomonas
fluorescens
[116]
Porphyridium
purpureum
Methanolic extracts B. subtilis E. coli
Pseudomonas
fluorescens
[116]
Rhodella reticulate Exopolysaccharides S. aureus
B. cereus
S. pyogenes
No effect [118]
Diatoms
Asterionella
glacialis
Whole cell S. aureus
S. epidermidis
M. luteus
Sarcina sp.
E. coli [119]
Attheya
longicornis
Methanolic extracts S. aureus
MRSA
No effect [120]
Chaetoceros
mulleri
Unsaturated fatty acid-containing lepidic fractions (triglycerides and
docosa-pentaenoic acid (DPA))
B. subtilis
S. aureus
E. coli [121,
122]
Navicula delognei Transphytol ester
Hexadecatetraenoic and octadecatetraenoic acids
S. aureus
S. epidermidis
S.
typhimurium
P. vulgaris
[123]
Phaeodactylum
tricornutum
Eicosapentaenoic acid [124]
Palmitoleic and hexadecatrienoic acids (HTA)
B. cereus
Bacillus
Weihenstephanensis
S. aureus
S. epidermidis
MRSA
No effect [125]
Rhizosolenia alata Various organic solvent extracts: acetone, chloroform, chloroform: methanol
(1:1), methanol: distilled water (4:1) and distilled water.
B. subtilis, S.
aureus
E. coli
P. aeruginosa
P. vulgaris
S. typhi
V. cholerae
[126]
Skeletonema
costatum
Aqueous and organic extracts: chloroform: methanol (2:1). B. subtilis
S. aureus
P. aeruginosa [95]
Hapotophytes
Isochrysis galbana Chlorophyll a derivative:
Pheophytin a and chlorophyllide a
S. aureus
Streptococcus
faecalis
S. pyogenes
Micrococcus sp.
Not tested [127,
128]
Adapted from Falaise et al. [105].
Table 4. Antibacterial activity observed in different extracts from microalgae against human pathogens.
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3. Conclusions
Cyanobacteria and microalgae have demonstrated a large potential as innovative sources of a
large variety of bioactive compounds, such as fatty acids, antioxidants, antifreeze proteins and
even antibiotics. While the characterization of substances as fatty acids is relatively well-
established and straightforward, an information gap still remains in the elucidation of struc-
tures of antibiotics. Despite the fact that a variety of extracts obtained frommicroalgae biomass
have demonstrated a clear antibiotic capacity, the structure of the molecules involved in the
observed activity still remains unclear. There is a clear and almost unrevealed potential in the
development of innovative nutraceutical and pharmaceutical industries based on cultivation
of microalgae and cyanobacteria and their exploitation in the production of bioactive sub-
stances. Cyanobacteria and microalgae adapted to extreme environments for sure have an
enormous potential that thorough bioprospecting approaches can help to unveil.
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